NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 83 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $369 | -18.0% | 116,800 | +0.3% | 0.00% | 0.0% |
Q2 2023 | $450 | +47.5% | 116,400 | +5.6% | 0.00% | – |
Q1 2023 | $305 | +70.4% | 110,200 | +10.8% | 0.00% | – |
Q4 2022 | $179 | -99.9% | 99,500 | +11.7% | 0.00% | – |
Q3 2022 | $189,000 | +10.5% | 89,100 | +40.1% | 0.00% | – |
Q2 2022 | $171,000 | +256.2% | 63,600 | +478.2% | 0.00% | – |
Q1 2022 | $48,000 | – | 11,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AH Equity Partners Bio II, L.L.C. | 16,298,006 | $16,298,000 | 8.49% |
Madrona Venture Group, LLC | 6,020,770 | $31,188,000 | 5.89% |
ArchPoint Investors | 1,449,551 | $7,509,000 | 2.23% |
Ally Bridge Group (NY) LLC | 1,225,060 | $6,346,000 | 2.22% |
Affinity Asset Advisors, LLC | 1,049,721 | $5,438,000 | 1.98% |
Tikvah Management LLC | 1,231,835 | $6,381,000 | 1.78% |
Bain Capital Life Sciences Investors, LLC | 2,000,000 | $10,360,000 | 0.82% |
AH Equity Partners LSV II, L.L.C. | 1,355,911 | $1,356,000 | 0.74% |
Perceptive Advisors | 18,222,302 | $94,390,000 | 0.73% |
SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $4,144,000 | 0.46% |